after returning from home, from travel. the fda authorized the use of the merck pill as a second at-home covid treatment. so that one reduced the risk of hospitalization and death in high-risk patients by 30%. right now, it is recommended for high-risk adults. do you see this as being a game-changer despite having a lower efficacy rate when compared to the pfizer pill? maybe merck get used as a booster? how do you see it? you know, first of all, i don t think any of us would say that we aren t happy that we have another option. remember the availability of these pills is going to be the biggest rate limiter in the next couple of months. and as i understand it, there s probably a larger quantity of the merck pill available. you know, it s a modest benefit, but if you are a high-risk individual and it lowers the risk of hospitalization and severe disease by 30%, you take it. we know now, of course, the monoclonal antibodies, two out of the three that we had
Microsoft has released a new Windows Server preview build 25075 today to Insiders. The new build brings an SMB NTLM authentication limiting feature that makes brute-force exploits very challenging.
From a number of libraries implementing fault tolerance features on the JVM, this post will look at Microprofile Fault Tolerance, Failsafe, and Resilience4J.